Profits and sales were higher at Walgreens this quarter, but its earnings report still failed to impress Wall Street. That shortfall between what was delivered and what was expected came down to a gross profit margin squeeze in its pharmacy business as generic drug costs increased and reimbursement rates dropped. Those trends have also been affecting fellow drug retailer Rite Aid. Also hurting shares, the company withdrew its previous 2016 guidance, as moves towards finalizing its acquisition of Alliance Boots clouded visibility. Management expects to issue updated fiscal goals late July, early August.

More from Video

3M's Chief Science Advocate on Advancing Healthcare, Autos and Young Scientists

3M's Chief Science Advocate on Advancing Healthcare, Autos and Young Scientists

Listen: Should You Buy Cisco Now?

Listen: Should You Buy Cisco Now?

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

It's Dumb to Think There Aren't Already Monopolies in Big Tech

It's Dumb to Think There Aren't Already Monopolies in Big Tech